ArticleCureus2025
Relevance of Routine Postoperative Biochemical Tests in Primary Hip and Knee Arthroplasty Patients: Assessing Necessity and Clinical Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of Cameriere's third molar maturity index (I3M) for forensic age estimation in a Moroccan population: a cross-sectional study.Forensic science, medicine, and pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Routine postoperative blood tests are common after primary hip and knee arthroplasty, but their value for every patient is uncertain in the era of enhanced recovery and routine transexamic acid. In the context of the United Kingdom (UK), this study sought to evaluate the clinical utility of next-day laboratory testing and to identify preoperative features that might permit selective testing. Methods A retrospective audit was performed in 99 consecutive primary total hip (n=51) and knee (n=48) arthroplasties undertaken at a tertiary centre. Demographic and laboratory data (pre- and post-operative haemoglobin, white cell count, platelets, electrolytes and creatinine/estimated glomerular filtration rate (eGFR)) were collected. Normality was assessed, and paired comparisons used a paired t-test or Wilcoxon signed-rank test as appropriate. Outcomes included blood transfusion, and other interventions prompted by test results, delays to discharge and readmissions. Statistical significance was set at p<0.05, and 95% confidence intervals were reported for mean differences. Results The cohort had a mean age of 69.5±10.1 years and comprised 50 men and 49 women. Mean haemoglobin fell from 136.33±12.83 g/L preoperatively to 115.81±13.03 g/L postoperatively. Mean haemoglobin change is 20.52 g/L (paired t=18.59; p<0.001), showing a statistically significant fall in haemoglobin after surgery. Mean white cell count rose and mean platelet count fell, consistent with an expected postoperative response. A total of 93 (93.9%) patients had normal renal indices, and 91 (91.9%) had normal electrolytes postoperatively. Moreover, nine patients (9.1%) were readmitted for clinical issues (wound problems, limb swelling or suspected venous thromboembolism (VTE) , infection or falls). No patient required blood transfusion. A total of 57 discharges (51.4%) were delayed while awaiting laboratory results. Conclusion Routine next-day blood tests after uncomplicated primary lower-limb arthroplasty produced predictable but infrequently actionable abnormalities and contributed to discharge delays. A selective, risk-based approach, directed at patients with low preoperative haemoglobin, impaired renal function, electrolyte derangement or other clinical concerns, appears safe and may reduce unnecessary testing, costs and length of stay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.